Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24-week Open-label Clinical Trial to Assess Tolerability and Antihypertensive Effect and in Hemodynamic Parameters and Arterial Stiffness of Fimasartan 60 mg Plus Amlodipine Besylate 5 mg Given Once a Day in Patients With Hypertension in Stadiums 2/3

NCT03294070 is registered in ClinicalTrials.gov with Centro Universitario de Ciencias de la Salud, Mexico as lead sponsor.

NCT NCT03294070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03294070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24-week Open-label Clinical Trial to Assess Tolerability and Antihypertensive Effect and in Hemodynamic Parameters and Arterial Stiffness of Fimasartan 60 mg Plus Amlodipine Besylate 5 mg Given Once a Day in Patients With Hypertension in Stadiums 2/3
Lead sponsor
Centro Universitario de Ciencias de la Salud, Mexico
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2017
Completion date
August 31, 2018
Enrollment
53 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arterial hypertension